These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15967270)

  • 1. Re: Bryan NP, Chapple CR. Frequency volume charts in the assessment and evaluation of treatment: how should we use them? Eur Urol 2004;46:636-40.
    Govindaraju SK; Neilson D
    Eur Urol; 2005 Jul; 48(1):171-2; author reply 172. PubMed ID: 15967270
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of daytime diuresis on voiding frequency and incontinence classification in children.
    Mahler B; Hagstroem S; Rittig N; Mikkelsen MM; Rittig S; Djurhuus JC
    J Urol; 2008 Jun; 179(6):2384-8. PubMed ID: 18433779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Chapple C, Khullar V, Gabriel Z, Dooley JA. The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysis. Eur Urol 2005;48:5-26.
    Okpara-Kamanu RI
    Eur Urol; 2005 Nov; 48(5):873-4. PubMed ID: 16137823
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Assessment of early continence after reconstruction of the periprostatic tissues in patients undergoing computer assisted (robotic) prostatectomy: results of a 2 group parallel randomized controlled trial: M. Menon, F. Muhletaler, M. Campos and J. O. Peabody J Urol 2008; 180: 1018-1023.
    Rocco B; Rocco F
    J Urol; 2009 Mar; 181(3):1500-1; author reply 1501. PubMed ID: 19157434
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Christopher R. Chapple, Vik Khullar, Zahava Gabriel, et al. The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis. Eur Urol 2008;54:543-62.
    Staskin DR; Oefelein MG
    Eur Urol; 2009 Mar; 55(3):e49-50; author reply e51. PubMed ID: 18829154
    [No Abstract]   [Full Text] [Related]  

  • 6. Global ratings of patient satisfaction and perceptions of improvement with treatment for urinary incontinence: validation of three global patient ratings.
    Burgio KL; Goode PS; Richter HE; Locher JL; Roth DL
    Neurourol Urodyn; 2006; 25(5):411-7. PubMed ID: 16652380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: Urs E. Studer, Laurence Collette, Peter Whelan, et al. Using PSA to guide timing of androgen deprivation in patients with T0-4 N0-2 M0 prostate cancer not suitable for local curative treatment (EORTC 30891). Eur Urol 2008;53:941-9 and re: John Anderson. Androgen-deprivation therapy--It's all a matter of timing. Eur Urol 2008;53:869-71.
    Kirollos MM
    Eur Urol; 2009 Feb; 55(2):e40-2; author reply e45-6. PubMed ID: 18760526
    [No Abstract]   [Full Text] [Related]  

  • 8. How do urinary diaries of women with an overactive bladder differ from those of asymptomatic controls?
    Fitzgerald MP; Ayuste D; Brubaker L
    BJU Int; 2005 Aug; 96(3):365-7. PubMed ID: 16042731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Chapple CR, Martinez-Garcia R, Selvaggi L, Toozs-Hobson P, Warnack W, Drogendijk T, Wright DM, Bolodeoku J. A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial. Eur Urol 2005;48:464-70.
    Jonas U; Rackley RR
    Eur Urol; 2006 Jan; 49(1):187-8; author reply 188-90. PubMed ID: 16310930
    [No Abstract]   [Full Text] [Related]  

  • 10. Pelvic floor muscle biofeedback in the treatment of urinary incontinence: a literature review.
    Glazer HI; Laine CD
    Appl Psychophysiol Biofeedback; 2006 Sep; 31(3):187-201. PubMed ID: 16983505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Women overestimate daytime urinary frequency: the importance of the bladder diary.
    Stav K; Dwyer PL; Rosamilia A
    J Urol; 2009 May; 181(5):2176-80. PubMed ID: 19296975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Urinary incontinence in the elderly].
    Mahamdia R; Beguin AM; Daniel MC; Le Quintrec JL
    Soins Gerontol; 2014; (109):23-7. PubMed ID: 25373265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bladder-health diaries: an assessment of 3-day vs 7-day entries.
    Dmochowski RR; Sanders SW; Appell RA; Nitti VW; Davila GW
    BJU Int; 2005 Nov; 96(7):1049-54. PubMed ID: 16225527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Teaching women to use a voiding diary.
    Sampselle CM
    Am J Nurs; 2003 Nov; 103(11):62-4. PubMed ID: 14625427
    [No Abstract]   [Full Text] [Related]  

  • 15. [Recommendations for the use of voiding diaries and symptom or quality of life questionnaires in the investigation of non-neurological female urinary incontinence].
    Le Normand L;
    Prog Urol; 2007 Nov; 17(6 Suppl 2):1252-63. PubMed ID: 18214137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary diaries: a comparison of data collected for three days versus seven days.
    Tincello DG; Williams KS; Joshi M; Assassa RP; Abrams KR
    Obstet Gynecol; 2007 Feb; 109(2 Pt 1):277-80. PubMed ID: 17267824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reliability of the frequency-volume chart in assessing lower urinary tract symptoms.
    Yap TL; Cromwell DA; Brown C; Emberton M; van der Meulen J
    BJU Int; 2007 Jul; 100(1):111-5. PubMed ID: 17552958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Number of daytime micturitions and volume voided per micturition in the evaluation of efficacy of drugs for overactive bladder: findings from randomized clinical trials.
    Colli E; Parazzini F; Olivieri L; Cipriani S; Bertozzi R; Meschia M; Montorsi F
    Eur Urol; 2007 Aug; 52(2):525-30. PubMed ID: 17449169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-reported urinary incontinence, voiding frequency, voided volume and pad-test results: variables in a prospective study in children.
    Bael AM; Lax H; Hirche H; Gäbel E; Winkler P; Hellström AL; van Zon R; Janhsen E; Güntek S; Renson C; van Gool JD;
    BJU Int; 2007 Sep; 100(3):651-6. PubMed ID: 17488303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naftopidil and propiverine hydrochloride for treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia and concomitant overactive bladder: a prospective randomized controlled study.
    Yokoyama T; Uematsu K; Watanabe T; Sasaki K; Kumon H; Nagai A;
    Scand J Urol Nephrol; 2009; 43(4):307-14. PubMed ID: 19396723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.